Little Cigar Oxidants
Part of paid clinical trials in Hershey, Pennsylvania.
- Sponsor
- Milton S. Hershey Medical Center
- Study ID
- NCT06310187
- Status
- Recruiting
Conditions
- Oxidative Stress
- Tobacco Use
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- High Oxidant Little Cigar — OTHERSubjects will be given a high oxidant little cigar to use for outcome measure data collection in the lab before and after product usage.
- Low Oxidant Little Cigar — OTHERSubjects will be given a low oxidant little cigar to use for outcome measure data collection in the lab before and after product usage.
- Usual Cigarette — OTHERSubjects will use their own cigarette for outcome measure data collection in the lab before and after product usage.
Study Details
Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups. These include a high oxidant little cigar exposure condition, a low oxidant little cigar exposure condition, and their usual cigarette. Biological samples will be collected before and after product usage.
Key Dates
- Start date
- Mar 23, 2026
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2029
- Completion
- Aug 31, 2029
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Group ASubjects will be given the high oxidant little cigar for their first laboratory visit. They will then be given the low oxidant little cigar for the second visit followed by using their own cigarette at the final laboratory visit.
- Experimental: Group BSubjects will be given the low oxidant little cigar for their first laboratory visit. They will then use their own cigarette for the second visit followed by being given the high oxidant little cigar at the final laboratory visit.
- Experimental: Group CSubjects will use their own cigarette for their first laboratory visit. They will then be given the high oxidant little cigar for the second visit followed by being given the low oxidant little cigar at the final laboratory visit.
Primary Outcome Measure
8-isoprostanes Concentration in Exhaled Breath Condensate [ Time Frame: -5 minutes ]
Central Contacts
- Joshua Muscat, Ph.D.7175318521
- Kenneth Houser, MS7175315473
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Penn State College of Medicine | Hershey | Pennsylvania | 17033 | Joshua Muscat, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Hershey, PA
By research site
Related Studies
- Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and BehaviorRecruiting · Penn State University · University Park, Pennsylvania
- The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent SmokersRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania
- Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette SmokersRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania
- Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to QuitRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania